packageRipretinib

ripretinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Ripretinib is a protein kinase inhibitor used to treat gastrointestinal stromal tumor. It is an approved anticancer medicine authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q27076996 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:ripretinib
ATC codes:L01EX19
DrugBank:DB14840
PubChem CID:71584930
Wikidata:Q27076996
formula:C24H21BrFN5O2
molar mass:510.367 g/mol (PubChem CID 71584930)
logP:4.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown